n-acetylneuraminic acid has been researched along with Afibrinogenemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brennan, SO; Laurie, A; Smith, M | 1 |
| Aznar, J; Navarro, G; Regañón, E; Salas, M; Vila, V | 1 |
| Borrell, M; Coll, I; Gómez, N; González, N; Rutllant, ML; Solá, J; Vila, L | 1 |
3 other study(ies) available for n-acetylneuraminic acid and Afibrinogenemia
| Article | Year |
|---|---|
Novel FGG variant (γ339C→S) confirms importance of the γ326-339 disulphide bond for plasma expression of newly synthesised fibrinogen.
Topics: Afibrinogenemia; Blood Coagulation Tests; Blood Loss, Surgical; Disulfides; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Humans; Middle Aged; Mutation; N-Acetylneuraminic Acid; Phenotype; Postoperative Hemorrhage; Protein Conformation; Structure-Activity Relationship | 2015 |
Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Fibrinopeptide A; Humans; Kinetics; N-Acetylneuraminic Acid; Sialic Acids | 1987 |
Two cases of dysfibrinogenemia characterized by abnormal FPB release: fibrinogen Madrid I & II.
Topics: Afibrinogenemia; Blood Coagulation Tests; Chromatography, High Pressure Liquid; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide B; Humans; Middle Aged; N-Acetylneuraminic Acid; Plasminogen; Protein Conformation; Sialic Acids; Thrombin; Tissue Plasminogen Activator | 1987 |